Case Reports
November 25, 2015
Vol. 80 No. 3 (2013): Cardiac series

A case of iatrogenic severe mitral regurgitation

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1514
Views
584
Downloads

Authors

Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson’s disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



“A Case of Iatrogenic Severe Mitral Regurgitation”. 2015. Monaldi Archives for Chest Disease 80 (3). https://doi.org/10.4081/monaldi.2013.75.